MarketScreener Strategies

GSK plc:  Priced for the storm, being built for thereafterGSK plc: Priced for the storm, being built for thereafter 16 September 2026 at 03:09 am AEST
GSK announces positive data from two clinical trialsGSK announces positive data from two clinical trials 14 September 2026 at 11:41 pm AEST
A No to BMS can open doors for a Yes to GSKA No to BMS can open doors for a Yes to GSK 12 August 2026 at 10:55 pm AEST
Goldman Sachs still cautious about GSKGoldman Sachs still cautious about GSK 30 July 2026 at 05:07 pm AEST
GSK plc:  Another beat; we appreciate the new CEO's aggressive intentGSK plc: Another beat; we appreciate the new CEO's aggressive intent 29 July 2026 at 04:23 am AEST
GSK plc:  A beat isn't enough; markets expected an outlook upgradeGSK plc: A beat isn't enough; markets expected an outlook upgrade 01 April 2026 at 12:57 am AEST
GSK plc:  Can bet on GSK’s gradually brightening futureGSK plc: Can bet on GSK’s gradually brightening future 11 March 2026 at 08:47 pm AEDT
GSK plc:  Eventually getting into its strideGSK plc: Eventually getting into its stride 06 February 2026 at 01:55 am AEDT
GSK:  shareholders urge company to step up reinventionGSK: shareholders urge company to step up reinvention 20 January 2026 at 09:20 pm AEDT
GSK PLC outlook improves amid merger speculationGSK PLC outlook improves amid merger speculation 30 December 2025 at 05:20 pm AEDT
mRNA rivals call truce as BioNTech prepares CureVac takeoverMRNA rivals call truce as BioNTech prepares CureVac takeover 08 August 2025 at 06:30 pm AEST
GSK plc :  Back on trackGSK plc : Back on track 03 May 2024 at 07:16 pm AEST
GSK:  UBS reiterates its recommendation on the shareGSK: UBS reiterates its recommendation on the share 02 May 2024 at 08:33 pm AEST
No results match your criteria
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!